Cencora buys retina business for $1.1 billion

Drug distributor Cencora has announced its intention to acquire the retina business of EyeSouth Partners for $1.1 billion. This strategic acquisition is designed to significantly expand Cencora's presence and capabilities within the specialized eye care market. The move aligns with the company's strategy to diversify its portfolio and strengthen its position in high-growth healthcare sectors. The deal is expected to enhance Cencora's service offerings and market reach in ophthalmology and related fields.